TP53 and neoplasm: Similarly, in breast PDOs, knocking out the tumor suppressor genes TP53, PTEN, RB transcriptional corepressor 1 (RB1) and NF1, led to the development of estrogen receptor-positive luminal tumors upon transplantation in mice, which responded to endocrine therapy and chemotherapy (Dekkers et al., 2020).